Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Site revision updated from v3.6.3 to v3.6.4, signaling a platform update rather than any modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-21T12:36:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Publications section added with a PubMed-derived citation and a note about automatic population from PubMed. The change provides direct literature references and clarifies data provenance for the study record.
    Difference
    0.2%
    Check dated 2026-07-14T08:51:22.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3. This is a minor version update and does not affect the study content or page functionality.
    Difference
    0.0%
    Check dated 2026-07-07T01:01:34.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.0 to v3.6.2, indicating a maintenance update to the ClinicalTrials.gov entry. This change does not modify study content or results.
    Difference
    0.0%
    Check dated 2026-06-29T18:47:06.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    New navigation/help sections were added to help users find joining information, contact details, how to read a study record, common questions, and how to join a study. The 'Intervention / Treatment' label was normalized to 'Intervention/Treatment' and the revision tag updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T09:42:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a new page build. The change does not alter the study details, eligibility, or results presented on the page.
    Difference
    0.0%
    Check dated 2026-06-08T04:52:31.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.